Medication info
Simvastatin 20 mg Tablets (Simvastatin)

Simvastatin 20 mg Tablets (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Yellow-brown oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200404707 · Notified 2004.03.25 · Insurance code 671700660

Summary

Main use
Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. Administration of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose as appropriate according to the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and regularly thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients taking this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg per day. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when administered alone or concomitantly with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Drug under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor closely.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose individually according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral artery disease
  • stroke
  • other cerebrovascular diseases
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary dysbetalipoproteinemia
  • severe hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases and decreases the risk of coronary events, myocardial infarction, stroke, and vascular surgeries in adult patients with a history of coronary heart disease, diabetes, peripheral artery disease, and stroke. It is also effective in treating hyperlipidemia, lowering cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol. It is particularly used in patients with familial hypercholesterolemia or severe hypertriglyceridemia. In pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, it is used alongside dietary therapy to lower total cholesterol and LDL cholesterol levels. This drug is used to improve cardiovascular health and significantly reduce the risk of heart disease.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. Administration of 5 ~ 40 mg of this drug once daily in the evening is recommended. Adjust the dose as appropriate according to the baseline LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and regularly thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients taking this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see 6. Drug Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this drug is administered concomitantly to patients taking verapamil, diltiazem, or dronedarone, the dose of this drug must not exceed 10 mg per day. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this drug is administered concomitantly to patients taking amiodarone, amlodipine, or ranolazine, the dose of this drug must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when administered alone or concomitantly with a bile acid sequestrant. When this drug is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Drug under Precautions for Use) and fenofibrate), the dose of this drug must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor closely.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose individually according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication is primarily used to lower serum cholesterol levels. If any muscle-related symptoms such as myalgia or weakness occur while taking this medication, it is important to inform a doctor immediately. There is an increased risk of serious muscle problems such as myopathy or rhabdomyolysis, especially when taking high doses or certain medications. Individuals with liver dysfunction or active liver disease should not take this medication. Pregnant women or women who may become pregnant, as well as breastfeeding women, should not use this medication. The risk of side effects is increased when taken with certain strong medications, so it's essential to discuss any concurrent medications with a doctor. Caution is also advised for those consuming alcohol excessively or having issues with liver, kidney, or thyroid function. Elderly patients and women are at higher risk for myopathy, and careful monitoring is necessary. Regular liver function tests and muscle-related tests should be conducted, and any unusual symptoms should be reported to healthcare professionals immediately. Additionally, the intake of certain foods such as grapefruit juice should be limited during treatment, and any new medications should be reported to healthcare providers. If planning pregnancy or if pregnant, do not take this medication and consult healthcare professionals.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 90 more
  • upper respiratory tract infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • ocular motor dysfunction
  • facial paresis
  • tremor
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • oculomotor myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • choledocholithiasis-related jaundice
  • fatty liver change
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle palsy
  • anemia
  • elevated aminotransferases
  • elevated alkaline phosphatase
  • elevated gamma-glutamyl transferase
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • limb paresthesia
  • numbness
  • cold sensation
  • reduced muscle strength
  • thrombocytopenia
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • interstitial lung disease
  • upper respiratory tract infection
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It should be kept at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow-brown oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.